Canaccord Genuity have a reputation for providing research for a fee from the company being researched. Not saying such research is useless, but care must be taken in using it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025